Natural polymers- based nanoparticles are widely used for biomedical purposes as they are highly biocompatible and biodegradable. Yet potential unexpected side effects have to be taken into account.
Shaping up polyphosphazenes: star dendritic molecular brushes
In a new study, researchers from the Johannes Kepler University in Linz, Austria, present for the first time a synthetic route to prepare polyphosphazenes with globular, highly branched morphologies (so called “star dendritic molecular brushes”) and controlled size.
First precise 9-arm 9-component star polymer
Precise synthesis of multi-armed and multi-component star-branched polymers was achieved using living anionic polymerization in a new iterative approach.
Modeling the degradation of star polymers
Researchers have developed a model for predicting the molecular weight distributions of star polymers undergoing mechanochemical degradation.
Three "star physicists" to become new Humboldt Professors in Germany
New Humboldt Professorships have been awarded, among them three prominent international physicists working on electronic, magnetic and superconducting materials.
Startups in materials science: interview with Jeffrey Carbeck
What materials discoveries had an impact on business the past 10 years? How will we do materials science startups in the future? Jeff Carbeck explains.
Clinical trial started in France for cancer nanomedicine
Patients with locally advanced cancers of the oral cavity or oropharynx to be treated with Nanobiotix’s NBTXR3 at the Institut Curie in Paris.
Startups in materials science: interview with Luc Scheres
We talk to Dr. Luc Scheres, CEO of Surfix BV, about issues with company startups, techniques in Surfix, and much more.
Startups in materials science: interview with Ben Wang
We chat to Ben Wang, founder of Svaya Nanotechnologies, about turning research into companies and the differences between Silicon Valley and academia.
Startups in materials science: interview with Jennifer Elisseeff
Scientist-entrepreneur Prof. Elisseeff from Johns Hopkins University on her latest biomedical materials venture Aegeria and translating research to business.